Patents by Inventor ANDRÉ WELBERS

ANDRÉ WELBERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
    Publication number: 20240051949
    Abstract: The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
    Type: Application
    Filed: November 24, 2021
    Publication date: February 15, 2024
    Inventors: Sara ALLASIA, Philippe ARZEL, Patrick CHALTIN, Amuri KILONDA, Arnaud MARCHAND, Thomas VANHERCK, Thomas VOETS, Joris VRIENS, Melanie REICH, André WELBERS
  • ARYL DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
    Publication number: 20230391739
    Abstract: The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
    Type: Application
    Filed: November 4, 2021
    Publication date: December 7, 2023
    Inventors: Sara ALLASIA, Philippe ARZEL, Patrick CHALTIN, Amuri KILONDA, Arnaud MARCHAND, Thomas VANHERCK, Thomas VOETS, Joris VRIENS, Melanie REICH, André WELBERS
  • 2,5-substituted pyrimidines
    Patent number: 9315490
    Abstract: The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: April 19, 2016
    Assignee: GRUENENTHAL GMBH
    Inventors: Ingo Konetzki, Tobias Craan, Florian Jakob, Antonio Nardi, Christian Hesslinger, Andre Welbers
  • Novel 2,5-Substituted Pyrimidines
    Publication number: 20160024053
    Abstract: The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
    Type: Application
    Filed: July 15, 2015
    Publication date: January 28, 2016
    Inventors: Ingo KONETZKI, Tobias CRAAN, Florian JAKOB, Antonio NARDI, Christian HESSLINGER, Andre WELBERS
  • PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES
    Publication number: 20150166505
    Abstract: The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to methods of using these compounds for the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.
    Type: Application
    Filed: December 18, 2014
    Publication date: June 18, 2015
    Applicant: GRÜNENTHAL GMBH
    Inventors: FELIX VOSS, SONJA NORDHOFF, SEBASTIAN WACHTEN, ANDRÉ WELBERS, STEFANIE RITTER